The use of 18F-Fluciclovine PET/CT Scan in the detection of recurrent prostate cancer in non-prostatectomy patients

A Salavati, M Gencturk, Y Koksel, A Schik, J Froelich - 2020 - Soc Nuclear Med
1247 Background: While the diagnostic performance of 18F-FACBC PET/CT imaging in the
restaging of patients with biochemical recurrence (BCR) after initial prostatectomy is well …

[HTML][HTML] Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤ 0.3 ng/mL) prostate-specific antigen levels

C Marcus, OA Abiodun-Ojo, AB Jani… - American Journal of …, 2021 - ncbi.nlm.nih.gov
The purpose of this study was to evaluate 18 F-fluciclovine PET/CT detection rates in the
evaluation of biochemical recurrence in prostate cancer patients with very low (≤ 0.3 ng/mL) …

18F-fluciclovine PET CT detection of biochemical recurrent prostate cancer at specific PSA thresholds after definitive treatment

JM Armstrong, CR Martin, C Dechet, K Morton… - … Oncology: Seminars and …, 2020 - Elsevier
Abstract Objectives To evaluate various Prostate-Specific Antigen (PSA) thresholds at which
a 18 F-fluciclovine PET scan could be considered in the setting of biochemical recurrent …

A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in …

A Salavati, M Gencturk, Y Koksel, AN Schik… - European Journal of …, 2021 - Springer
Abstract Purpose 18 F-Fluciclovine PET imaging has been increasingly used in the
restaging of prostate cancer patients with biochemical recurrence (BCR); however, its …

Performance of 18F-Fluciclovine PET/CT for detection of recurrent prostate cancer, with a focus on low PSA levels (< 1 ng/mL): A single institution experience.

V Sue, A Brown, E Mittra, N Mallak - 2020 - Soc Nuclear Med
1246 Objectives: The purpose of this study is to evaluate the detection rate of 18 F-
Fluciclovine PET/CT relative to the level of PSA in patients with biochemical recurrence of …

18F-fluciclovine PET/CT detection of recurrent prostate carcinoma in patients with serum PSA≤ 1 ng/mL after definitive primary treatment

JR England, J Paluch, LK Ballas… - Clinical nuclear …, 2019 - journals.lww.com
Purpose The aims of this study were to report on our initial experience using 18 F-
fluciclovine PET/CT to detect recurrent prostate carcinoma in patients with low serum …

18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels< 2.00 ng/mL

D Garza, A Kandathil, Y Xi… - Nuclear Medicine …, 2021 - journals.lww.com
Objective To establish the detection rate of prostate cancer recurrence following definitive
therapy by 18 F-fluciclovine PET/computed tomography (CT) in patients with biochemical …

Positive findings on 18F-fluciclovine PET/CT in patients with suspected recurrent prostate cancer and PSA levels≤ 0.5 and≤ 0.3 ng/ml

P Lovec, B Savir-Baruch, G Gupta… - International Journal of …, 2018 - redjournal.org
Results Overall, 101 men met selection criterion. Thirty of 101 men had a PSA≤ 0.5 (median
0.25, interquartile range [IQR] 0.20-0.36) and 20/30 men had a PSA≤ 0.3 (median 0.23, IQR …

Utility of 18F-Fluciclovine PET/CT for Detecting Prostate Cancer Recurrence in Patients With Low (< 1 ng/mL) or Very Low (< 0.3 ng/mL) Prostate-Specific Antigen …

Y Wang, DZ Chow, E Ebert, S Tajmir… - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. We reviewed a retrospective series of 126 18F-fluciclovine PET/CT studies of
patients with biochemically recurrent prostate cancer at low (< 1 ng/mL) and very low (< 0.3 …

Patterns of recurrence, detection rates, and impact of 18-F fluciclovine PET/CT on the management of men with recurrent prostate cancer

J Michael, AH Khandani, R Basak, HJ Tan, TJ Royce… - Urology, 2021 - Elsevier
Objective To evaluate the characteristics of FACBC PET/CT in detecting recurrent prostate
cancer after radiation or prostatectomy. The secondary aim was to determine the impact of …